1. Fibroblast growth factor 21 serum concentrations in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM2). (August 2018) Authors: Walus-miarka, M.; Idzior-Walus, B.; Kapusta, M.; Trojak, A.; Miarka, P.; Malecki, M.T. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗